Topics in Critical Care and Disaster Management
7-Night Scandinavia and Russia Cruise Conference
Round-trip Stockholm, Sweden
July 23 - 30, 2017
14 AMA PRA Category 1 Credit(s)™
14 Contact Hours
3 Hours of Pharmacology for NPs
$895 for Physicians, Attorneys, Psychologists, Doctors of Pharmacy & Dentists
$695 for Physician Assistants, Nurse Practitioners
$495 Nurses, Residents, Students & Others
BIAS FREE CME - No Commercial Support was provided for this CME activity.
Professor of Intensive Care Medicine
University College London
Head, Research Department of Clinical Physiology, Division of Medicine
Director, Bloomsbury Institute of Intensive Care Medicine
Editor-in-Chief, Intensive Care Medicine experimental (ICMx)
NIHR Senior Investigator 2009-2017
Mervyn Singer is Professor of Intensive Care Medicine at University College London, UK. He trained in medicine at St Bartholomew's Hospital Medical College, London and then undertook subsequent junior doctor posts in hospitals around the London area. He performed his doctorate research thesis developing a novel hemodynamic monitoring tool using esophageal Doppler ultrasonography; the subsequent technology (CardioQ) is now used in >30 countries worldwide. He then began formal critical care training in an academic rotation at University College London in 1989 and was appointed Professor in 2001.
He is Director of the Bloomsbury Institute of Intensive Care Medicine and runs a research group totaling 15 people performing bench-to-bedside research. Specific interests include sepsis and multi-organ failure, tissue oxygenation, infection, novel diagnostics and monitoring. Funding comes from the Wellcome Trust, UK Medical Research Council, European Union, and UK National Institute of Health Research (NIHR) among others. He has published widely, with multiple papers in the New England Journal of Medicine, Lancet and JAMA. Apart from the above-mentioned esophageal Doppler monitor, he has developed a novel tissue PO2 monitor (gauging the adequacy of tissue perfusion) entering clinical trials in 2016, and a novel drug inducing a 'suspended animation' state intended for ischaemia-reperfusion injury that is scheduled to go into man also in 2016. He is also the clinical lead investigator of studies on novel diagnostics for sepsis and infection, and the first intensivist to be appointed a Senior Investigator by the NIHR.
He lectures widely and has delivered four plenary lectures at the annual Congresses of the European Society of Intensive Care Medicine and the US Society of Critical Care Medicine. He has authored/edited several textbooks including the Oxford Textbook of Critical Care and the Oxford Handbook of Critical Care. He is currently Editor-in-Chief of Intensive Care Medicine Experimental (ICMx), co-chair of the new Sepsis Redefinitions Task Force, Council Member of the International Sepsis Forum, Critical Care Theme Lead of the NIHR Health Informatics Collaborative, and does 13 clinical on-call weeks per annum in the ICU.
Charles L. Sprung MD, JD, MCCM, FCCP
Director Emeritus, General Intensive Care Unit
Department of Anesthesiology and Critical Care Medicine
Hadassah Hebrew University Medical Center
Professor of Medicine and Critical Care Medicine
Professor Charles Sprung is the Director Emeritus of the General Intensive Care Unit in the Department of Anesthesiology and Critical Care Medicine at Hadassah Hebrew University Medical Center in Jerusalem, Israel where he has worked for the last 27 years. He was previously the Director of the Section of Critical Care Medicine in the Department of Medicine at the VA Medical Center and the University of Miami for 13 years. He graduated the University of Miami School of Law in 1988. Professor Sprung was the Chairman of the Committee on Ethics Section of the US Society of Critical Care Medicine and of the European Society of Intensive Care Medicine (ESICM) for many years.
Professor Sprung has been active in research particularly studying sepsis, septic shock and ethical issues for more than 35 years. He was a member of the ACCP/SCCM consensus conference on definitions of sepsis in 1991 and a member of the recent 2012 and current 2016 Surviving Sepsis Campaign guidelines. He has participated in many sepsis studies including those of encephalopathy and treatments with corticosteroids, monoclonal antibodies to endotoxin and tumor necrosis factor, interleukin-1 receptor antagonist, antithrombin III, tissue factor pathway inhibitor, human activated protein C and recombinant platelet-activating factor. He has also served as a member of Clinical Evaluation and Data Safety and Monitoring Committees for many phase III, multicenter sepsis trials. Professor Sprung coordinated the prospective, multicenter European trial of corticosteroids in septic shock, Corticus. He was the Coordinator of several multi-center studies in ethics including End of Life Decision Making and Procedures in European Intensive Care Units – ETHICUS, Systematic Study of General Ethical Principles Involved in End of Life Decisions for Patients in European Intensive Care Units – ETHICATT, Triage Decision Making for the Elderly in European Intensive Care units – ELDICUS and Worldwide Consensus for End of Life Decisions- Welpicus.
The Hadassah General ICU has treated more terror victims than any other ICU in the world. In addition, Professor Sprung served as the Chairman of the European Society of Intensive Care Medicine Ethics Section Task Force for ICU Triage for Disasters and Pandemic Influenza which produced recommendations for the 2009 H1N1 influenza pandemic and he was a member of the recent American College of Chest Physicians Task Force for Mass Critical Care during a Disaster which also published recommendations.
Professor Sprung has been or continues to be a member of several international committees of medical organizations, world health organizations and governmental agencies. He has published extensively on all of the above and multiple ICU areas with more than 300 original articles and 50 book chapters. He received the 2011 ESICM Medal for outstanding contributions to both ESICM and to the development of Intensive Care Medicine worldwide and the Roger C. Bone Advances in End-of-Life Care Award from the CHEST Foundation of the American College of Chest Physicians in October 2013. He was the 2015 Bonei Zion Prize Recipient for Science & Medicine- an award recognizing outstanding Anglo Olim who encapsulate the spirit of modern-day Zionism by contributing in a significant way towards the State of Israel.
Our staff can assist you with all your travel arrangements.
- Pulmonary Edema and Acute Respiratory Distress Syndrome (ARDS)
- Update of the Surviving Sepsis Campaign Guidelines for Severe Sepsis and Septic Shock
- ICU triage including triage for multiple casualty events
- How to improve your communication skills?
- Mass disasters and multiple casualty events
- End of life decision making in the ICU
- Excellence in Medicine
- Novel monitoring and diagnostics in critical care – exciting new horizons
- Are critically ill patients predetermined to live or die?
- De-stressing the distressed ICU patient – a novel paradigm worth pursuing?
- Understanding lactate
- Managing bad asthma
- Managing diabetic ketoacidosis
- Hemodynamics made easy
Accreditation: Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation: Continuing Education, Inc. designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Each physician should claim only the credit commensurate with the extent of their participation in the activity.
Osteopathic Physicians: This program is eligible for Category 2 credit with the American Osteopathic Association (AOA) .
Canadian Physicians: This activity is eligible for Section 1 credits in the Royal College’s Maintenance of Certification (MOC) Program . Participants must log into MAINPORT to claim this activity.
US or Canadian Family Physicians: Please let us know if you require AAFP Prescribed Credits.
Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Nurse Practitioners: can claim either ANCC Contact Hours or AMA PRA Category 1 Credits™ as needed.
Pharmacology credits are identified on individual activities.
Accredited status does not imply endorsement by Continuing Education, Inc./University at Sea or ANCC of any commercial products displayed or used with an activity.
Approval: Continuing Education, Inc. is approved by the American Psychological Association to sponsor continuing education for psychologists. Continuing Education, Inc. maintains responsibility for this program and its content.
Designation: As an organization approved by the American Psychological Association, Continuing Education, Inc. is offering this activity for a maximum of 14 hours of continuing education credit. Full attendance is required; no partial credit will be given for partial attendance.
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.
|DATE||PORT OF CALL||ARRIVE||DEPART|
|Sun Jul 23||Stockholm, Sweden
|Mon Jul 24||Helsinki, Finland
||11:00 am||6:00 pm|
|Tue Jul 25||St. Petersburg, Russia
* See visa information, below
|Wed Jul 26||St. Petersburg, Russia
|Thu Jul 27||Tallinn, Estonia
||7:00 am||4:00 pm|
|Fri Jul 28||Riga, Latvia
||11:00 am||7:00 pm|
|Sat Jul 29||At Sea - Cruising
|Sun Jul 30||Stockholm, Sweden
Please note that our shore excursions are operated separately and
independently of those offered by the cruise line.